Arbuckle Stuart A 4
4 · RHYTHM PHARMACEUTICALS, INC. · Filed Jun 20, 2024
Insider Transaction Report
Form 4
Arbuckle Stuart A
Director
Transactions
- Award
Restricted Stock Units
2024-06-18+4,000→ 4,000 total→ Common Stock (4,000 underlying) - Award
Stock Option (right to buy)
2024-06-18+14,000→ 14,000 totalExercise: $41.39Exp: 2034-06-17→ Common Stock (14,000 underlying)
Footnotes (3)
- [F1]The options fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F3]The restricted stock units fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date.